-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H49vLJbVG7u1C8Z+kifhwGfUYSAi2WnaKjVuncatYSyBkSB+IxJh62zR/wTDscF2 L9x5ECF7UYjtKjNqIYgmeg== 0001104659-07-025778.txt : 20070404 0001104659-07-025778.hdr.sgml : 20070404 20070404132138 ACCESSION NUMBER: 0001104659-07-025778 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060105 FILED AS OF DATE: 20070404 DATE AS OF CHANGE: 20070404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAUKIEN JOERG C CENTRAL INDEX KEY: 0001133646 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 07748008 MAIL ADDRESS: STREET 1: C/O BRUKER DALTONICS CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER BIOSCIENCES CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 4/A 1 a4a.xml 4/A X0202 4/A 2006-01-05 2006-01-09 0 0001109354 BRUKER BIOSCIENCES CORP BRKR 0001133646 LAUKIEN JOERG C UHLANDSTRASSE 10 ETTLINGEN-BRUCHHAUSEN 2M D-76275 GERMANY 1 0 1 0 Stock Option (Right to Buy) See Footnote 0 D On January 9, 2006, the reporting person filed a Form 4 reporting an award of options to purchase 6,000 shares of common stock. As a result of administrative error, the grant was never fully documented. Additionally, the number of derivative securities reported in Table II, Column 9 incorrectly reflected the number of shares of common stock beneficially owned by the reporting person rather than the number of derivative securities beneficially owned. Exhibit 24 - Power of Attorney /s/ Constance Andrews, as attorney-in-fact 2007-04-03 EX-24 2 ex-24.htm EX-24

EXHIBIT 24

 

POWER OF ATTORNEY

 

Know all by these presents that the undersigned hereby constitutes and appoints each of Constance Andrews and Brian Monahan of Bruker BioSciences Corporation, signing singly, the undersigned’s true and lawful attorney-in-fact to:

 

(1)                                  execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Bruker BioSciences Corporation (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

 

(2)                                  do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

 

(3)                                  take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 21st day of March, 2007.

 

/s/ Joerg C. Laukien

 

 

WITNESS:

 

/s/ Roger Deutsch

 

 

March 21, 2007

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----